Preview

L.O. Badalyan Neurological Journal

Advanced search

Subcortical band heterotopia: analysis of 5 cases

https://doi.org/10.46563/2686-8997-2022-3-3-127-134

Abstract

Subcortical band heterotopia (SBH) is a diffuse deterioration of cortical development, which is characterized by the location of heterotopic neurons in deep and subcortical regions of the brain parallel to the cortex, which creates the illusion of duplication of the cortex, from what this variant was named the «double cortex» syndrome. 

Data of five patients including three girls and 2 boys  were analyzed. The average age was 12.6 years (from 5 to 15). In all cases, heterotopia was bilaterally symmetrical: in 2 cases — diffuse, in 1 it was fronto-parietal, in 1 — temporal-occipital, and in 1 it was fronto-parietal-occipital. Concomitant cerebral malformations were presented in all patients: ventriculomegaly in 5 cases (100%), frontal pachygyria in 1 case (20.0%), diffuse pachygyria in 1 case (20.0%), and dysgyria in 1 case (20.0%). All 5 (100%) patients had epilepsy. The age of onset of epileptic seizures was 6.1 [5.6; 7.5] years. In 3 (60.0%) people epilepsy was focal, in 2 (40.0%) — generalized. There were the following types of epileptic seizures: infantile spasms — 1 (20.0%), focal — 3 (60.0%), tonic-clonic — 4 (80.0%), myoclonic — 2 (40.0%), attacks of cessation of motor activity — 1 (20.0%), atonic — 1 (20.0%). Status epilepticus and febrile-provoked seizures were no observed in any case. Interictal epileptiform activity was presented in all cases: regional in 3 (60.0%), diffuse in 1 (20.0%), and multiregional + diffuse in 1 (20.0%). Drug resistant course was in 3 (60.0%) people. Intellectual impairments were detected in 3 (60.0%) patients: mild — in 1 (20.0%), moderate — in 1 (20.0%), severe — in 1 (20.0%). In 2 (40.0%) observations, intelligence was intact, and in both cases these were patients without drug-resistant epilepsy and without concomitant pachygyria. Speech disorder was detected in 3 (60.0%) people, mild movement disorders — in 1 (20.0%), microcephaly — in 1 (20.0%). 

Thus, the leading clinical manifestation of SBH is epilepsy with a predominantly drug resistant course. More data are needed on the possibility of using alternative drug treatments.

Contribution:
Kulikova S.L. — concept, study design, patient data collection and analysis, literature review;
Likhachev S.A. — concept, study design;
Zmachynskaya O.L. — article correction, literature review;
Siz M.A. — EEG monitoring analysis of patients, included in the study.
All co-authors — approval of the final version of the manuscript, responsibility for the integrity of all parts of the manuscript.

Acknowledgments. The study had no sponsorship.

Conflict of interest. The authors declare no conflict of interest.

Received: July 20, 2022
Accepted: August 25, 2022
Published: September 30, 2022

About the Authors

Sviatlana L. Kulikova
Republican Research and Clinical Center of Neurology and Neurosurgery of the Ministry of Health of the Republic of Belarus
Russian Federation

MD, PhD, leading researcher of the neurological department of the Republican Research and Clinical Center of Neurology and Neurosurgery of the Ministry of Health of the Republic of Belarus, 220114, Minsk.

e-mail: sviatlana.kulikova@gmail.com



Sergey A. Likhachev
Republican Research and Clinical Center of Neurology and Neurosurgery of the Ministry of Health of the Republic of Belarus
Russian Federation


Olga L. Zmachynskaya
Republican Research and Clinical Center of Neurology and Neurosurgery of the Ministry of Health of the Republic of Belarus
Russian Federation


Marina A. Siz
Republican Research and Clinical Center of Neurology and Neurosurgery of the Ministry of Health of the Republic of Belarus
Russian Federation


References

1. Severino M., Geraldo A.F., Utz N., Tortora D., Pogledic I., Klonowski W., et al. Definitions and classification of malformations of cortical development: practical guidelines. Brain. 2020; 143(10): 2874-94. https://doi.org/10.1093/brain/awaa174

2. Harvey A.S., Cross J.H., Shinnar S., Mathern G.W. ILAE Pediatric Epilepsy Surgery Survey Taskforce. Defining the spectrum of international practice in pediatric epilepsy surgery patients. Epilepsia. 2008; 49(1): 146-55. https://doi.org/10.1111/j.1528-1167.2007.01421.x

3. Stevenson R.E., Hall J.G., Goodman R., eds. Human Malformations and Related Anomalies. Oxford: Oxford University Press; 1993.

4. Jacobs M.P., Fischbach G.D., Davis M.R. Dichter M.A., Dingledine R., Lowenstein D.H., et al. Future directions for epilepsy research. Neurology. 2001; 57(9): 1536-42. https://doi.org/10.1212/wnl.57.9.1536

5. Kuzniecky R., Murro A., King D., Morawetz R., Smith J., Powers R., et al. Magnetic resonance imaging in childhood intractable partial epilepsies: pathologic correlations. Neurology. 1993; 43(4): 681-7. https://doi.org/10.1212/wnl.43.4.681

6. Mischel P.S., Nguyen L.P., Vinters H.V. Cerebral cortical dysplasia associated with pediatric epilepsy: review of neuropathologic features and proposal for a grading system. J. Neuropathol. Exp. Neurol. 1995; 54(2): 137-53. https://doi.org/10.1097/00005072-199503000-00001

7. Jirsch J.D., Bernasconi N., Villani F., Vitali P., Avanzini G., Bernasconi A. Sensorimotor organization in double cortex syndrome. Hum. Brain Mapp. 2006; 27(6): 535-43. https://doi.org/10.1002/hbm.20197

8. Gleeson J.G. Classical lissencephaly and double cortex (subcortical band heterotopia): LIS1 and doublecortin. Curr. Opin. Neurol. 2000; 13(2): 121-5. https://doi.org/10.1097/00019052-200004000-00002

9. Donato D.N., Timms A.E., Aldinger K.A., Mirzaa G.M., Bennett J.T., Collins S., et al. Analysis of 17 genes detects mutations in 81% of 811 patients with lissencephaly. Genet. Med. 2018; 20(11): 1354-64. https://doi.org/10.1038/gim.2018.8

10. Vriend I., Oegema R. Genetic causes underlying grey matter heterotopia. Eur. J. Paediatr. Neurol. 2021; 35: 82-92. https://doi.org/10.1016/j.ejpn.2021.09.015

11. Harding B. Gray matter heterotopia. In: Guerrini R., Andermann F., Canapicchi R., Roger J., Zifkin B.G., Pfanner P., eds. Dysplasias of Cerebral Cortex and Epilepsy. New York: Lippincott-Raven; 1996: 81-8.

12. Barkovich A.J., Guerrini R., Battaglia G., Kalifa G., N’Guyen T., Parmeggiani A., et al. Band heterotopia: correlation of outcome with magnetic resonance imaging parameters. Ann. Neurol. 1994; 36(4): 609-17. https://doi.org/10.1002/ana.410360409

13. Spencer-Smith M., Leventer R., Jacobs R., Luca C., Anderson V. Neuropsychological profile of children with subcortical band heterotopia. Dev. Med. Child Neurol. 2009; 51(11): 909-16. https://doi.org/10.1111/j.1469-8749.2009.03309.x

14. D’Agostino M.D., Bernasconi A., Das S., Bastos A., Valerio R.M., Palmini A., et al. Subcortical band heterotopia (SBH) in males: clinical, imaging and genetic findings in comparison with females. Brain. 2002; 125(11): 2507-22. https://doi.org/10.1093/brain/awf248

15. Bernasconi A., Martinez V., Rosa-Neto P., D’Agostino D., Bernasconi N., Berkovic S., et al. Surgical resection for intractable epilepsy in “double cortex” syndrome yields inadequate results. Epilepsia. 2002; 42(9): 1124-9. https://doi.org/10.1046/j.1528-1157.2001.39900.x

16. Gilliam F.G., Ssentongo P., Sather M., Kawasawa Y.I. Case report: PAFAH1B1 mutation and posterior band heterotopia with focal temporal lobe epilepsy treated by responsive neurostimulation. Front. Neurol. 2021; 12: 779113. https://doi.org/10.3389/fneur.2021.779113

17. Matsuhashi A., Matsuo T., Kumada S. Incremental changes in interhemispheric functional connectivity after two-stage corpus callosotomy in a patient with subcortical band heterotopia. Epilepsy Behav. Rep. 2022; 18: 100525. https://doi.org/10.1016/j.ebr.2022.100525

18. Franco A., Pimentel J., Campos A.R., Morgado C., Pinelo S., Ferreira A.G., et al. Stimulation of the bilateral anterior nuclei of the thalamus in the treatment of refractory epilepsy: two cases of subcortical band heterotopia. Epileptic. Disord. 2016; 18(4): 426-30. https://doi.org/10.1684/epd.2016.0878

19. Kumada T., Miyajima T., Kimura N., Saito K., Shimomura H., Oda N., et al. Modified Atkins diet for the treatment of nonconvulsive status epilepticus in children. J. Child Neurol. 2010; 25(4): 485-9. https://doi.org/10.1177/0883073809347597

20. Yan H., Toyota E., Anderson M., Abel T.J., Donner E., Kalia S.K., et al. A systematic review of deep brain stimulation for the treatment of drug-resistant epilepsy in childhood. J. Neurosurg. Pediatr. 2018; 23(3): 274-84. https://doi.org/10.3171/2018.9.PEDS18417

21. Berg A.T., Langfitt J.T., Testa F.M., Levy S.R., DiMario F., Westerveld M., et al. Global cognitive function in children with epilepsy: a community-based study. Epilepsia. 2008; 49(4): 608-14. https://doi.org/10.1111/j.1528-1167.2007.01461.x


Review

For citations:


Kulikova S.L., Likhachev S.A., Zmachynskaya O.L., Siz M.A. Subcortical band heterotopia: analysis of 5 cases. L.O. Badalyan Neurological Journal. 2022;3(3):127-134. (In Russ.) https://doi.org/10.46563/2686-8997-2022-3-3-127-134

Views: 1138


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2686-8997 (Print)
ISSN 2712-794X (Online)